Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP8 | P22894 | 17/20 | 0.68 |
| ▸ | MMP3 | P08254 | 9/20 | 0.68 |
| ▸ | MMP1 | P03956 | 1/20 | 0.51 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | MMP7 | P09237 | 1/20 | 0.51 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.49 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6010325 | 0.89 | MMP8 (0.67) | MMP8MMP3MMP1MMP7TAS2R14 | |
| SCHEMBL7299752 | 0.85 | MCL1 (0.55) | MMP8MMP3TAS2R14POLBAPOBEC3A | |
| SCHEMBL6010087 | 0.83 | MMP8 (0.82) | MMP8MMP3POLBAPOBEC3AAPOBEC3G | |
| SCHEMBL14837362 | 0.81 | MMP8 (0.54) | MMP8MMP3 | |
| SCHEMBL6010103 | 0.79 | MMP8 (1.00) | MMP8MMP3MMP1MMP2MMP7 | |
| SCHEMBL6873972 | 0.79 | MMP8 (0.76) | MMP8MMP3MMP1MMP2MMP7 | |
| SCHEMBL6010114 | 0.77 | MMP8 (0.84) | MMP8MMP3MMP1POLBAPOBEC3A | |
| SCHEMBL1024395 | 0.76 | MMP8 (0.50) | MMP8MMP3 | |
| SCHEMBL13856619 | 0.72 | POLB (0.72) | MMP8MMP3TAS2R14POLBAPOBEC3A | |
| SCHEMBL5098064 | 0.72 | POLB (0.72) | MMP8MMP3TAS2R14POLBAPOBEC3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0861236-B2 | CYCLIC AND HETEROCYCLIC N-SUBSTITUTED ALPHA-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-08-16 | — | — | EP | claimed |
| EP-0861236-B1 | CYCLIC AND HETEROCYCLIC N-SUBSTITUTED ALPHA-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS | HOECHST AG (DE) | 2002-02-13 | — | — | EP | claimed |
| EP-0861236-B2 | CYCLIC AND HETEROCYCLIC N-SUBSTITUTED ALPHA-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS | SANOFI AVENTIS DEUTSCHLAND (DE) | 2006-08-16 | — | — | EP | disclosed |
| EP-0861236-B1 | CYCLIC AND HETEROCYCLIC N-SUBSTITUTED ALPHA-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS | HOECHST AG (DE) | 2002-02-13 | — | — | EP | disclosed |
| EP-0861236-A1 | CYCLIC AND HETEROCYCLIC N-SUBSTITUTED ALPHA-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS | HOECHST AKTIENGESELLSCHAFT (DE) | 1998-09-02 | — | — | EP | disclosed |
| WO-1997018194-A1 | CYCLIC AND HETEROCYCLIC N-SUBSTITUTED α-IMINOHYDROXAMIC AND CARBOXYLIC ACIDS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-05-22 | — | — | WO | disclosed |